Vitamin B12 deficiency, peripheral neuropathy, general weakness, and vitamin C deficiency
Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 19902019 data
Its chemical name is cobalamin, derived from its central cobalt atom
Medical professionals must evaluate individual health profiles, monitor treatment response, and adjust dosing schedules accordingly
Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk